欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/1575/003
药品名称Ropivacaine Kabi 5 mg/ml solution for injection
活性成分
    • Ropivacaine hydrochloride 5.0 mg/ml
剂型Solution for injection
上市许可持有人Fresenius Kabi Nederland B.V. Amersfoortseweg 10 E 3712 BC Huis ter Heide, Utrecht Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Hungary (HU)
      Ropivacaine Fresenius Kabi
    • Lithuania (LT)
    • Denmark (DK)
    • Belgium (BE)
    • France (FR)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Cyprus (CY)
      ROPIVACAINE KABI 5mg/ml SOLUTION FOR INJECTION
    • Romania (RO)
      Ropivacaina Kabi 5 mg/ml solutie injectabila
    • Latvia (LV)
    • Malta (MT)
      Ropivacaine Kabi 5 mg/ml
    • Estonia (EE)
    • Poland (PL)
      Ropivacaine Kabi
    • Austria (AT)
许可日期2010/03/29
最近更新日期2025/09/04
药物ATC编码
    • N01BB09 ropivacaine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase